{"public_id":"cl_6393f35a9aec485e2ad36c549f2fafcd","status":"active","superseded_by_public_id":null,"corpus_id":44012753,"text":"BET inhibition may represent a novel treatment strategy for a subset of ARID1A-mutated ovarian clear cell carcinomas.","confidence":0.92,"paper":{"corpus_id":44012753,"title":"ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors","url":"https://sah.borca.ai/papers/44012753"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.92,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_21d0262b8f652fa16a64701455676083","name":"ARID1A mutation","description":"A genetic alteration affecting the ARID1A gene in ovarian clear cell carcinoma cells.","types":["genetic alteration"],"url":"https://sah.borca.ai/concepts/co_21d0262b8f652fa16a64701455676083"},{"public_id":"co_b5c9adab7956c137a8357e53568b2463","name":"ovarian clear cell carcinoma","description":"A histologic subtype of ovarian cancer studied here as the disease context.","types":["cancer type"],"url":"https://sah.borca.ai/concepts/co_b5c9adab7956c137a8357e53568b2463"},{"public_id":"co_dfb6d945311f5de89e15c7971265f94a","name":"BET inhibition","description":"Therapeutic inhibition of bromodomain and extra terminal domain family proteins.","types":["therapeutic strategy"],"url":"https://sah.borca.ai/concepts/co_dfb6d945311f5de89e15c7971265f94a"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_6393f35a9aec485e2ad36c549f2fafcd"}